News · 22 January 2024
Strategic partnership accelerates long-term manufacturing growth
Collaboration with industry experts and investors continues to strengthen Sam-Ace’s capacity and capabilities.
In 2021, Sam-Ace entered a strategic partnership with a consortium of industry experts and investors to accelerate manufacturing capacity and long-term growth.
That collaboration supported the commissioning of our state-of-the-art Beta-Lactam Manufacturing Facility in 2024.
Together, we remain focused on building indigenous pharmaceutical capacity that improves access to affordable, high-quality medicines.
Keep reading
Related stories
News
Sam-Ace commissions new beta lactam manufacturing facility
Our expanded Osun State complex strengthens capacity for essential antibiotics across Nigeria and the region.
Insight
Expanding access to oral rehydration therapy
How fluid and electrolyte replacement remains central to our public health commitment.
Insight
Building a culture of quality every day
From raw materials to release testing — how our teams uphold NAFDAC GMP standards.